Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
PROPRANOLOL
(1967)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
PROPRANOLOL
×
Maximum Phase:
4
First Approval:
1967
UNII:
9Y8NXQ24VQ
Molecule Type:
Small molecule
Molecular Formula:
C16H21NO2
Molecular Weight:
259.35
AlogP:
2.58
PSA:
41.49
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ETHAMBUTOL
(1967)
Small molecule
Unknown
Unknown
Approved
Tuberculosis
ETHAMBUTOL
×
Maximum Phase:
4
First Approval:
1967
UNII:
8G167061QZ
Molecule Type:
Small molecule
Molecular Formula:
C10H24N2O2
Molecular Weight:
204.31
AlogP:
-0.29
PSA:
64.52
HBD:
4.0
HBA:
#RotB:
9.0
Source:
DOXYCYCLINE HYCLATE
(1967)
Small molecule
Bacterial 70S ribosome inhibitor
INJECTION; ORAL; PERIODONTAL
Approved
Acne Vulgaris
DOXYCYCLINE HYCLATE
×
Maximum Phase:
4
First Approval:
1967
UNII:
19XTS3T51U
Molecule Type:
Small molecule
Molecular Formula:
C46H58Cl2N4O18
Molecular Weight:
1025.89
AlogP:
-0.35
PSA:
181.62
HBD:
6.0
HBA:
#RotB:
2.0
Source:
ERYTHROMYCIN ESTOLATE
(1967)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Unknown
ERYTHROMYCIN ESTOLATE
×
Maximum Phase:
4
First Approval:
1967
UNII:
XRJ2P631HP
Molecule Type:
Small molecule
Molecular Formula:
C52H97NO18S
Molecular Weight:
1056.4
AlogP:
2.75
PSA:
199.98
HBD:
4.0
HBA:
#RotB:
9.0
Source:
ERYTHROMYCIN PROPIONATE
(1967)
Small molecule
Unknown
Unknown
Approved
Unknown
ERYTHROMYCIN PROPIONATE
×
Maximum Phase:
4
First Approval:
1967
UNII:
HB75CIT999
Molecule Type:
Small molecule
Molecular Formula:
C40H71NO14
Molecular Weight:
790.0
AlogP:
2.75
PSA:
199.98
HBD:
4.0
HBA:
#RotB:
9.0
Source:
DEXTROTHYROXINE
(1967)
Small molecule
Thyroid hormone receptor agonist
Unknown
Approved
Cardiovascular Diseases
DEXTROTHYROXINE
×
Maximum Phase:
4
First Approval:
1967
UNII:
4W9K63FION
Molecule Type:
Small molecule
Molecular Formula:
C15H11I4NO4
Molecular Weight:
776.87
AlogP:
4.56
PSA:
92.78
HBD:
3.0
HBA:
#RotB:
5.0
Source:
CHLORPROTHIXENE
(1967)
Small molecule
Dopamine D2 receptor antagonist
INJECTION; ORAL
Approved
Psychotic Disorders
CHLORPROTHIXENE
×
Maximum Phase:
4
First Approval:
1967
UNII:
9S7OD60EWP
Molecule Type:
Small molecule
Molecular Formula:
C18H18ClNS
Molecular Weight:
315.87
AlogP:
5.19
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
3.0
Source:
ETHACRYNIC ACID
(1967)
Small molecule
Sodium-(potassium)-chloride cotransporter 2 inhibitor
ORAL
Approved
Cardiovascular Diseases; Fibrosis; Heart Failure; Kidney Diseases; Nephrotic Syndrome; Pulmonary Edema
ETHACRYNIC ACID
×
Maximum Phase:
4
First Approval:
1967
UNII:
M5DP350VZV
Molecule Type:
Small molecule
Molecular Formula:
C13H12Cl2O4
Molecular Weight:
303.14
AlogP:
3.61
PSA:
63.6
HBD:
1.0
HBA:
#RotB:
6.0
Source:
HALOPERIDOL
(1967)
Small molecule
D2-like dopamine receptor inverse agonist
INJECTION; ORAL
Approved
Conduct Disorder; Psychotic Disorders; Schizophrenia; Tics; Tourette Syndrome
HALOPERIDOL
×
Maximum Phase:
4
First Approval:
1967
UNII:
J6292F8L3D
Molecule Type:
Small molecule
Molecular Formula:
C21H23ClFNO2
Molecular Weight:
375.87
AlogP:
4.43
PSA:
40.54
HBD:
1.0
HBA:
#RotB:
6.0
Source:
METHENAMINE
(1967)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
METHENAMINE
×
Maximum Phase:
4
First Approval:
1967
UNII:
J50OIX95QV
Molecule Type:
Small molecule
Molecular Formula:
C6H12N4
Molecular Weight:
140.19
AlogP:
-1.02
PSA:
12.96
HBD:
0.0
HBA:
#RotB:
0.0
Source:
HYDROXYUREA
(1967)
Small molecule
Ribonucleoside-diphosphate reductase RR1 inhibitor
ORAL
Approved
Anemia, Sickle Cell; Carcinoma, Squamous Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanoma; Neoplasms
HYDROXYUREA
×
Maximum Phase:
4
First Approval:
1967
UNII:
X6Q56QN5QC
Molecule Type:
Small molecule
Molecular Formula:
CH4N2O2
Molecular Weight:
76.05
AlogP:
-0.96
PSA:
75.35
HBD:
3.0
HBA:
#RotB:
0.0
Source:
PROTRIPTYLINE
(1967)
Small molecule
Unknown
Unknown
Approved
Depressive Disorder
PROTRIPTYLINE
×
Maximum Phase:
4
First Approval:
1967
UNII:
4NDU154T12
Molecule Type:
Small molecule
Molecular Formula:
C19H21N
Molecular Weight:
263.38
AlogP:
4.3
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BETAMETHASONE VALERATE
(1967)
Small molecule
Glucocorticoid receptor agonist
TOPICAL
Approved
Eye Diseases; Hemorrhoids; Lung Diseases, Obstructive; Nasal Obstruction; Skin Diseases
BETAMETHASONE VALERATE
×
Maximum Phase:
4
First Approval:
1967
UNII:
9IFA5XM7R2
Molecule Type:
Small molecule
Molecular Formula:
C27H37FO6
Molecular Weight:
476.59
AlogP:
3.64
PSA:
100.9
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PENTAZOCINE LACTATE
(1967)
Small molecule
Sigma opioid receptor modulator
INJECTION
Approved
Unknown
PENTAZOCINE LACTATE
×
Maximum Phase:
4
First Approval:
1967
UNII:
1P2XIB510O
Molecule Type:
Small molecule
Molecular Formula:
C22H33NO4
Molecular Weight:
375.51
AlogP:
3.88
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
2.0
Source:
DOXYCYCLINE
(1967)
Small molecule
Bacterial 70S ribosome inhibitor
ORAL
Approved
Acne Vulgaris; Anthrax; Bacterial Infections; Brucellosis; Cholera; Gonorrhea; Infections; Malaria; Periodontitis; Pneumonia; Psittacosis; Rocky Mountain Spotted Fever; Rosacea; Spotted Fever Group Rickettsiosis; Tularemia; Typhus, Epidemic Louse-Borne
DOXYCYCLINE
×
Maximum Phase:
4
First Approval:
1967
UNII:
N12000U13O
Molecule Type:
Small molecule
Molecular Formula:
C22H26N2O9
Molecular Weight:
462.46
AlogP:
-0.35
PSA:
181.62
HBD:
6.0
HBA:
#RotB:
2.0
Source:
DEXTROTHYROXINE SODIUM
(1967)
Small molecule
Thyroid hormone receptor agonist
ORAL
Approved
Unknown
DEXTROTHYROXINE SODIUM
×
Maximum Phase:
4
First Approval:
1967
UNII:
0H00N2AHSP
Molecule Type:
Small molecule
Molecular Formula:
C15H12I4NNaO5
Molecular Weight:
816.87
AlogP:
4.56
PSA:
92.78
HBD:
3.0
HBA:
#RotB:
5.0
Source:
THIABENDAZOLE
(1967)
Small molecule
Tubulin inhibitor
ORAL
Approved
Helminthiasis
THIABENDAZOLE
×
Maximum Phase:
4
First Approval:
1967
UNII:
N1Q45E87DT
Molecule Type:
Small molecule
Molecular Formula:
C10H7N3S
Molecular Weight:
201.25
AlogP:
2.69
PSA:
41.57
HBD:
1.0
HBA:
#RotB:
1.0
Source:
CLOMIPHENE CITRATE
(1967)
Small molecule
Estrogen receptor alpha modulator
ORAL
Approved
Hemorrhage; Infertility; Polycystic Ovary Syndrome
CLOMIPHENE CITRATE
×
Maximum Phase:
4
First Approval:
1967
UNII:
1B8447E7YI
Molecule Type:
Small molecule
Molecular Formula:
C32H36ClNO8
Molecular Weight:
598.09
AlogP:
6.56
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
9.0
Source:
DIPHENIDOL HYDROCHLORIDE
(1967)
Small molecule
Muscarinic acetylcholine receptor M1 antagonist
ORAL
Approved
Unknown
DIPHENIDOL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1967
UNII:
DG355XWQ4T
Molecule Type:
Small molecule
Molecular Formula:
C21H28ClNO
Molecular Weight:
345.91
AlogP:
4.19
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AMANTADINE
(1968)
Small molecule
Unknown
Unknown
Approved
Parkinson Disease
AMANTADINE
×
Maximum Phase:
4
First Approval:
1968
UNII:
BF4C9Z1J53
Molecule Type:
Small molecule
Molecular Formula:
C10H17N
Molecular Weight:
151.25
AlogP:
1.91
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
0.0
Source:
DICLOXACILLIN SODIUM
(1968)
Small molecule
Penicillin-binding protein inhibitor
ORAL
Approved
Infections
DICLOXACILLIN SODIUM
×
Maximum Phase:
4
First Approval:
1968
UNII:
4HZT2V9KX0
Molecule Type:
Small molecule
Molecular Formula:
C19H18Cl2N3NaO6S
Molecular Weight:
510.33
AlogP:
3.2
PSA:
112.74
HBD:
2.0
HBA:
#RotB:
4.0
Source:
DICLOXACILLIN
(1968)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
DICLOXACILLIN
×
Maximum Phase:
4
First Approval:
1968
UNII:
COF19H7WBK
Molecule Type:
Small molecule
Molecular Formula:
C19H17Cl2N3O5S
Molecular Weight:
470.33
AlogP:
3.2
PSA:
112.74
HBD:
2.0
HBA:
#RotB:
4.0
Source:
FENTANYL CITRATE
(1968)
Small molecule
Mu opioid receptor agonist
BUCCAL; INJECTION; NASAL; ORAL; SUBLINGUAL; TRANSMUCOSAL
Approved
Breakthrough Pain; Neoplasms; Pain
FENTANYL CITRATE
×
Maximum Phase:
4
First Approval:
1968
UNII:
MUN5LYG46H
Molecule Type:
Small molecule
Molecular Formula:
C28H36N2O8
Molecular Weight:
528.6
AlogP:
4.14
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
6.0
Source:
GRAMICIDIN
(1968)
Small molecule
Cell membrane inhibitor
Unknown
Approved
Unknown
GRAMICIDIN
×
Maximum Phase:
4
First Approval:
1968
UNII:
5IE62321P4
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZATHIOPRINE
(1968)
Small molecule
Amidophosphoribosyltransferase inhibitor
ORAL
Approved
Arthritis, Rheumatoid; Immune System Diseases
AZATHIOPRINE
×
Maximum Phase:
4
First Approval:
1968
UNII:
MRK240IY2L
Molecule Type:
Small molecule
Molecular Formula:
C9H7N7O2S
Molecular Weight:
277.27
AlogP:
1.15
PSA:
115.42
HBD:
1.0
HBA:
#RotB:
3.0
Source:
DEFEROXAMINE MESYLATE
(1968)
Small molecule
Iron chelating agent
INJECTION
Approved
Iron Overload
DEFEROXAMINE MESYLATE
×
Maximum Phase:
4
First Approval:
1968
UNII:
V9TKO7EO6K
Molecule Type:
Small molecule
Molecular Formula:
C26H52N6O11S
Molecular Weight:
656.8
AlogP:
0.92
PSA:
205.84
HBD:
6.0
HBA:
#RotB:
23.0
Source:
FENTANYL
(1968)
Small molecule
Mu opioid receptor agonist
BUCCAL; SUBLINGUAL; TRANSDERMAL
Approved
Acute Pain; Cancer Pain; Chronic Pain; Migraine Disorders; Neoplasms; Pain
FENTANYL
×
Maximum Phase:
4
First Approval:
1968
UNII:
UF599785JZ
Molecule Type:
Small molecule
Molecular Formula:
C22H28N2O
Molecular Weight:
336.48
AlogP:
4.14
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
6.0
Source:
CARBAMAZEPINE
(1968)
Small molecule
Sodium channel alpha subunit blocker
INTRAVENOUS; ORAL
Approved
Bipolar Disorder; Epilepsies, Partial; Epilepsy; Glossopharyngeal Nerve Diseases; Seizures; Trigeminal Neuralgia
CARBAMAZEPINE
×
Maximum Phase:
4
First Approval:
1968
UNII:
33CM23913M
Molecule Type:
Small molecule
Molecular Formula:
C15H12N2O
Molecular Weight:
236.27
AlogP:
3.39
PSA:
46.33
HBD:
1.0
HBA:
#RotB:
0.0
Source:
NORGESTREL
(1968)
Small molecule
Progesterone receptor agonist
ORAL
Approved
Hemorrhage
NORGESTREL
×
Maximum Phase:
4
First Approval:
1968
UNII:
3J8Q1747Z2
Molecule Type:
Small molecule
Molecular Formula:
C21H28O2
Molecular Weight:
312.45
AlogP:
3.88
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ACETAMINOPHEN
(1968)
Small molecule
Anandamide amidohydrolase inhibitor
INJECTION; INTRAVENOUS; ORAL; RECTAL
Approved
Acute Pain; Arthritis; Back Pain; Common Cold; Dysmenorrhea; Fever; Headache; Influenza, Human; Migraine Disorders; Muscle Cramp; Pain; Pharyngitis; Toothache
ACETAMINOPHEN
×
Maximum Phase:
4
First Approval:
1968
UNII:
362O9ITL9D
Molecule Type:
Small molecule
Molecular Formula:
C8H9NO2
Molecular Weight:
151.16
AlogP:
1.35
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
1.0
Source:
DEFEROXAMINE
(1968)
Small molecule
Unknown
Unknown
Approved
Unknown
DEFEROXAMINE
×
Maximum Phase:
4
First Approval:
1968
UNII:
J06Y7MXW4D
Molecule Type:
Small molecule
Molecular Formula:
C25H48N6O8
Molecular Weight:
560.69
AlogP:
0.92
PSA:
205.84
HBD:
6.0
HBA:
#RotB:
23.0
Source:
AMANTADINE HYDROCHLORIDE
(1968)
Small molecule
Glutamate [NMDA] receptor antagonist
ORAL
Approved
Infections; Influenza, Human; Intracranial Arteriosclerosis; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary; Parkinsonian Disorders
AMANTADINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1968
UNII:
M6Q1EO9TD0
Molecule Type:
Small molecule
Molecular Formula:
C10H18ClN
Molecular Weight:
187.71
AlogP:
1.91
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
0.0
Source:
HYDROXYAMPHETAMINE HYDROBROMIDE
(1969)
Small molecule
Adrenergic receptor agonist
OPHTHALMIC
Approved
Unknown
HYDROXYAMPHETAMINE HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
1969
UNII:
59IG47SZ0E
Molecule Type:
Small molecule
Molecular Formula:
C9H14BrNO
Molecular Weight:
232.12
AlogP:
1.28
PSA:
46.25
HBD:
2.0
HBA:
#RotB:
2.0
Source:
PIPERACETAZINE
(1969)
Small molecule
Unknown
ORAL
Approved
Unknown
PIPERACETAZINE
×
Maximum Phase:
4
First Approval:
1969
UNII:
KL6248WNW4
Molecule Type:
Small molecule
Molecular Formula:
C24H30N2O2S
Molecular Weight:
410.58
AlogP:
4.98
PSA:
43.78
HBD:
1.0
HBA:
#RotB:
7.0
Source:
TROLEANDOMYCIN
(1969)
Small molecule
70S ribosome inhibitor
ORAL
Approved
Bacterial Infections
TROLEANDOMYCIN
×
Maximum Phase:
4
First Approval:
1969
UNII:
C4DZ64560D
Molecule Type:
Small molecule
Molecular Formula:
C41H67NO15
Molecular Weight:
813.98
AlogP:
3.62
PSA:
184.19
HBD:
0.0
HBA:
#RotB:
9.0
Source:
DOXEPIN HYDROCHLORIDE
(1969)
Small molecule
Norepinephrine transporter inhibitor
ORAL; TOPICAL
Approved
Alcoholism; Bipolar Disorder; Depression; Depressive Disorder; Dermatitis, Atopic; Sleep Initiation and Maintenance Disorders
DOXEPIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
1969
UNII:
3U9A0FE9N5
Molecule Type:
Small molecule
Molecular Formula:
C19H22ClNO
Molecular Weight:
315.84
AlogP:
3.96
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
3.0
Source:
1
2
…
12
13
14
15
16
17
18
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA